Actually when I first saw this PR I giggled and said to myself YES, there are entities that are scrambling. How can you stop a company that is making money quarter after quarter? A little biotech none the less!!! This is for real. I can’t predict Nasrat’s next move but I believe he has always had his eye on the prize of a buyout for over $2/a share. I’d take $2! anything over is icing on the cake!
Market Data 
Markets 
AI
